Price T Rowe Associates Inc Sop Hi A Genetics Sa Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$3.84 - $5.3 $265,198 - $366,028	-69,062 Reduced 6.72%	958,500 $4.3 Million
Q1 2023 May 15, 2023	BUY	$1.98 - $5.49 $222,346 - $616,505	112,296 Added 12.27%	1,027,562 $5.11 Million
Q4 2022 Feb 14, 2023	SELL	$1.71 - $2.98 $68,810 - $119,915	-40,240 Reduced 4.21%	915,266 $1.89 Million
Q3 2022 Nov 14, 2022	SELL	$2.63 - $5.1 $2.59 Million - $5.03 Million	-985,776 Reduced 50.78%	955,506 $2.51 Million
Q2 2022 Aug 15, 2022	SELL	$2.46 - $7.91 $931,006 - $2.99 Million	-378,458 Reduced 16.31%	1,941,282 $7.03 Million
Q1 2022 May 16, 2022	SELL	$7.31 - $15.6 $457,342 - $975,998	-62,564 Reduced 2.63%	2,319,740 $17.9 Million
Q4 2021 Feb 14, 2022	BUY	$12.35 - $18.8 $294,708 - $448,624	23,863 Added 1.01%	2,382,304 $33.6 Million
Q3 2021 Nov 15, 2021	BUY	$15.18 - $19.77 $35.8 Million - $46.6 Million	2,358,441 New	2,358,441 $41.3 Million

18.6M

5.9K

300

Ticker SOPH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 64,153,700
Market Cap $203M
Description
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.